You are here: Industry Insights > lung disease

News List

Insmed Initiates ARIKAYCE Trial for MAC Lung Disease americanpharmaceuticalreview
January 11, 2021
Insmed announced the first patient was dosed in the frontline clinical trial program of ARIKAYCE® (amikacin liposome inhalation suspension) in patients with nontuberculous mycobacterial (NTM) lung disease caused by Mycobacterium avium complex (MAC).
CPI Scales Up Manufacturing of Pyocin S5 contractpharma
December 15, 2020
CPI, an independent technology innovation center and founding member of the UK Government’s High Value Manufacturing Catapult, has completed Project GAIA, establishing a large-scale manufacturing process for Pyocin S5, a protein antibiotic that could ...
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung diseas expresspharma
May 21, 2020
Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic sclerosis-associated ILD (SSc-ILD).
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus prnewswire
March 18, 2020
EmphyCorp Inc., a Private Corporation, is proud to announce that EmphyCorp Rx N115 Non-Steroidal Nasal Spray with no known side effects for Pulmonary Fibrosis, Cystic Fibrosis ...
Ozone, Wood Smoke Raise Odds of COPD in Smokers and Nonsmokers drugs
January 06, 2020
High levels of ozone and wood smoke each increase the risk for lung diseases like chronic obstructive pulmonary disease (COPD) among smokers and nonsmokers alike, two new studies find.
Incidence of Nontuberculous Mycobacteria Lung Disease Rising drugs
December 26, 2019
The incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in the United States, according to a study published online in the Annals of the American Thoracic Society.
Canadians with rare lung disease are relieved to now have publicly funded access to potentially life-extending treatment firstwordpharma
December 02, 2018
At the end of a successful Pulmonary Hypertension Awareness Month, members of the Pulmonary Hypertension Association of Canada (PHA Canada) and Scleroderma Canada (SC) have come together to thank provincial governments for providing the majority of Canadi
Inhaler users get about half as much medicine as they should from each puff worldpharmanews
March 02, 2017
Tens of millions of Americans with lung disease use metered-dose inhalers each day...